Safety of AI-Powered Virtual Assistant in Outpatient Management of Heart Failure
Recruiting · NCT06400927 · Interventional (participants receive a specific treatment) · Lead sponsor: East and North Hertfordshire NHS Trust
View the official record on ClinicalTrials.gov →Interventions studied
HF-guided VAStandard-of-care
What this trial is about
The aim of this pilot randomized study is to examine whether integrating the SIRIO-HF virtual assistant (VA) into the outpatient management of participants recently discharged from hospital with a new diagnosis of heart failure (HF), may reduce the need for regular medical assessment and the healthcare burden, reduce variability in healthcare, and meet with participant satisfaction, without compromising participant safety and overall care quality.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Age ≥ 18 years
- Newly diagnosed HF with New York Heart Association class II-III symptoms at discharge
Exclusion criteria
- Known prior history of HF
- Severe comorbidities that could affect protocol adherence, in the opinion of the investigator
- Alternative diagnosis for symptoms such as chronic obstructive pulmonary disease
- Dementia or other cognitive impairment
- Currently involved in another interventional clinical trial
Where it is running
1 location listed.
- East and North Hertfordshire NHS Trust - Stevenage, Hertfordshire, United Kingdom